EGFR and non-small cell lung carcinoma: Furthermore, in the case of EGFR-NSCLC where tumor tissue may be hard to obtain, genotyping for the BIM deletion may be performed on normal tissue, e.g from peripheral blood mononuclear cells or even a buccal swab.